Accession Number: | 0001179110-20-002960 |
Date: | 2020-03-01 |
Issuer: | BLUEPRINT MEDICINES CORP (BPMC) |
Original Submission Date: |
LANDSITTEL MICHAEL
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-03-01 | A | 12,500 | a | $0.00 | 17,750 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 54.13 | 2020-03-01 | deemed execution date | A | 25,000 (a) | 2030-03-01 | common stock 25,000 | $54.13 | 25,000 | direct |
ID | footnote |
---|---|
f1 | the reported transaction involved the reporting person's receipt of a grant of 12,500 restricted stock units under issuer's 2015 stock option and incentive plan. the reporting person has reported prior awards of restricted stock units in table ii of form 4. the total reported in column 5 includes the 12,500 newly awarded restricted stock units, and 5,250 previously reported restricted stock units, 1,313 of which vested on march 1, 2020. |
f2 | this option vests with respect to 1/48th of the shares underlying the option on april 1, 2020 and as to an additional 1/48th of the shares underlying the option each month thereafter. |